Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$89.05 -0.99 | -1.1%
03/23/17 - 04:14 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 1.70B 1.03B 580.41M 1.21B
Cost of Sales 149.06M 62.17M 60.99M 81.91M
Gross Operating Profit 1.55B 970.17M 519.43M 1.13B
Selling, General, and Administrative Expenses 432.83M 376.57M 305.41M 356.19M
Research & Development 1.05B 995.92M 855.51M 882.10M
Operating Income before D & A (EBITDA) 72.60M -402.33M -641.49M -108.22M
Depreciation & Amortization 61.40M 62.34M 63.26M 48.37M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 4.13M -6.71M 30.40M 6.89M
Special Income / Charges 0.00 0.00 0.00 -412.90M
Total Income Before Interest Expenses (EBIT) 14.07M -473.59M -725.27M -603.12M
Interest Expense 81.43M 84.21M 72.86M 22.93M
Pre-Tax Income -67.37M -557.80M -798.13M -626.04M
Income Taxes 16.66M 30.38M 6.96M -122.42M
Minority Interest 28.02M -31.85M -4.19M -242.52M
Net Income From Continuing Operations -84.03M -588.18M -741.83M -503.62M
Net Income From Discontinued Operations 0.00 0.00 -912.00K -183.93M
Net Income From Total Operations -84.03M -588.18M -742.75M -687.55M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -112.05M -556.33M -738.55M -445.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-82.77M -585.98M -690.91M -50.20M
Preferred Dividends
Net Income Available To Common -84.03M -588.18M -741.83M -503.62M
Basic EPS from Continuing Ops. -0.46 -2.31 -3.14 -2.24
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.26
Basic EPS from Total Operations -0.46 -2.31 -3.14 -1.98
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.46 -2.31 -3.14 -1.98
Basic Normalized Net Income/Share -0.45 -2.30 -2.92 -0.22
EPS fr Continuing Ops. -0.46 -2.31 -3.14 -2.24
EPS fr Discontinued Ops 0.00 0.00 0.00 0.26
EPS fr Total Ops. -0.46 -2.31 -3.14 -1.98
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.46 -2.31 -3.14 -1.98
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.45 -2.30 -2.92 -0.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter